title: Serum-soluble herpes virus entry mediator levels reflect disease severity and Th2 environment in cutaneous T-cell lymphoma.
authors.forename: Tomomitsu
authors.initials: T
authors.lastname: Miyagaki
authors.forename: Makoto
authors.initials: M
authors.lastname: Sugaya
authors.forename: Hiraku
authors.initials: H
authors.lastname: Suga
authors.forename: Hanako
authors.initials: H
authors.lastname: Ohmatsu
authors.forename: Hideki
authors.initials: H
authors.lastname: Fujita
authors.forename: Yoshihide
authors.initials: Y
authors.lastname: Asano
authors.forename: Yayoi
authors.initials: Y
authors.lastname: Tada
authors.forename: Takafumi
authors.initials: T
authors.lastname: Kadono
authors.forename: Shinichi
authors.initials: S
authors.lastname: Sato
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000097:blood* / Q000276:immunology / Q000473:pathology; D011379:Prognosis; D053240:Receptors, Tumor Necrosis Factor, Member 14 / Q000097:blood*; D012720:Severity of Illness Index; D012751:Sezary Syndrome / Q000097:blood* / Q000276:immunology / Q000473:pathology; D012867:Skin / Q000276:immunology / Q000473:pathology; D012878:Skin Neoplasms / Q000097:blood* / Q000276:immunology / Q000473:pathology; D018418:Th2 Cells / Q000276:immunology*; D059016:Tumor Microenvironment; D053326:Tumor Necrosis Factor Ligand Superfamily Member 14 / Q000097:blood; D015854:Up-Regulation
chemical_list: D014408:Biomarkers, Tumor; D053240:Receptors, Tumor Necrosis Factor, Member 14; C506028:TNFRSF14 protein, human; C505914:TNFSF14 protein, human; D053326:Tumor Necrosis Factor Ligand Superfamily Member 14; D007073:Immunoglobulin E